Omacetaxine Mepesuccinate

US Brand Name(s): Ceflatonin, Synribo

Use in Cancer Treatment

Omacetaxine mepesuccinate is to treat the following conditions:

Chronic myelogenous leukemia is a kind of cancer that affects the blood cells. This is for individuals with chronic phase or accelerated phase illness for whom tyrosine kinase inhibitors will not be effective or who have grown worse after taking at least two of them.

Omacetaxine mepesuccinate is also under research for use in the treatment of various cancers.

 Detailed scientific definition – Definition from the NCI Drug Dictionary 

Omacetaxine Mepesuccinate – MedlinePlus Information

A summary of key facts regarding this medication in layman’s terms, which may contain the following:

  • Cautions about this medicine
  • What is the use and how?
  • Whom should you consult before taking it?
  • What you should know about it before using it?
  • Other drugs that might interact with it
  • Possible negative effects

Drugs are frequently under research to see whether they can assist treat or prevent conditions other than those already prevalent. This patient information leaflet covers uses which have been under authorization. Much of the material, though, might also apply to authorized uses that are being investigated.